Завершено
Фаза II
Россия
patiromer; placebo · Relypsa, Inc.
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multiple-Dose Study to Evaluate the Effects of Patiromer in Heart Failure Patients